Prevention of Early Readmission in Elderly Congestive Heart Failure Patients

NCT00000475 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2016-02-18

No results posted yet for this study

Summary

To assess the impact of a multidisciplinary treatment program on three-month readmission-free survival in elderly congestive heart failure patients.

Conditions

Interventions

BEHAVIORAL

health education

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Michael Rich · Jewish Hospital and St. Mary's Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION

Eligibility

Min Age
70 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-04-30
Completion
1995-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000475 on ClinicalTrials.gov